Open AccessSuccessful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation
Author(s) -
Jairo H Barrantes,
Jamel Ortoleva,
Erika R OʼNeil,
Erik E. Suarez,
Sharon B. Larson,
Aniket S Rali,
Cara Agerstrand,
Lorenzo Grazioli,
Subhasis Chatterjee,
Marc Anders
Publication year - 2020
Publication title -
asaio journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 66
eISSN - 1538-943X
pISSN - 1058-2916
DOI - 10.1097/mat.0000000000001357
Subject(s) - ards , extracorporeal membrane oxygenation , medicine , covid-19 , acute respiratory distress , pregnancy , intensive care medicine , respiratory distress , intensive care , obstetrics , anesthesia , lung , disease , infectious disease (medical specialty) , biology , genetics
There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.